InnoCare Pharma Ltd. (INCPF)
1.85
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
InnoCare Pharma Profit Margin (Quarterly) : 22.55% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 22.55% |
| March 31, 2026 | 19.38% |
| December 31, 2025 | 56.86% |
| September 30, 2025 | -9.46% |
| June 30, 2025 | -14.31% |
| March 31, 2025 | 3.80% |
| December 31, 2024 | -53.75% |
| September 30, 2024 | -6.34% |
| June 30, 2024 | -48.86% |
| March 31, 2024 | -89.48% |
| December 31, 2023 | -53.66% |
| September 30, 2023 | -69.99% |
| June 30, 2023 | -222.8% |
| March 31, 2023 | -7.60% |
| December 31, 2022 | -28.31% |
| September 30, 2022 | -202.8% |
| Date | Value |
|---|---|
| June 30, 2022 | -256.4% |
| March 31, 2022 | -101.3% |
| December 31, 2021 | -250.0% |
| September 30, 2021 | 34.14% |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -367.0K% |
| September 30, 2019 | -134.6K% |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | -12.80K% |
| September 30, 2018 | -55.10K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 12.63% |
| Return on Assets | 8.90% |
| Return on Invested Capital | 10.14% |
| Gross Profit Margin (Quarterly) | 86.94% |
| Operating Margin (Quarterly) | 12.18% |
| Return on Net Operating Assets | 53.14% |